Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Jaguar Health (JAGX) Long-Term Debt Issuances (2016 - 2025)

Jaguar Health (JAGX) has disclosed Long-Term Debt Issuances for 8 consecutive years, with -$3000.0 as the latest value for Q2 2025.

  • Quarterly Long-Term Debt Issuances changed N/A to -$3000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Dec 2025, changed N/A year-over-year, with the annual reading at $3.4 million for FY2025, N/A changed from the prior year.
  • Long-Term Debt Issuances for Q2 2025 was -$3000.0 at Jaguar Health, down from $3.4 million in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $11.0 million in Q1 2021, with the low at -$2.0 million in Q3 2022.
  • Average Long-Term Debt Issuances over 3 years is $3.7 million, with a median of $3.4 million recorded in 2025.
  • The sharpest move saw Long-Term Debt Issuances surged 3035.71% in 2021, then crashed 45.33% in 2022.
  • Over 3 years, Long-Term Debt Issuances stood at $11.0 million in 2021, then crashed by 118.45% to -$2.0 million in 2022, then soared by 99.85% to -$3000.0 in 2025.
  • According to Business Quant data, Long-Term Debt Issuances over the past three periods came in at -$3000.0, $3.4 million, and -$2.0 million for Q2 2025, Q1 2025, and Q3 2022 respectively.